Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial

Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: امید نیک پیام

کلمات کلیدی: : Zinc supplement, Obesity, Anthropometric measurements, hs-CRP, Insulin resistance

نشریه: 9311 , 2019 , 11 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله امید نیک پیام
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه کمیته تحقیقات دانشجویی
کد مقاله 70308
عنوان فارسی مقاله Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial
عنوان لاتین مقاله Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: The present study was designed to determine whether zinc supplementation would increase the efects of restricted calorie diet (RCD) on obesity. Methods and materials: A randomized, double-blind clinical trial was performed on 40 obese subjects who were randomly assigned to receive zinc supplements (30 mg/day) or placebo for a period of 15-weeks. Both groups were under a restricted calorie diet (~300 kcal lower than the estimated energy requirement). Anthropometric measurements, biochemical markers, appetite, and dietary intakes were determined during the study period. Results: The reductions of body weight, body mass index, waist circumference, and hip circumference were signifcantly higher in the zinc group compared to the placebo group (P=0.032, 0.025, 0.003, and 0.0001, respectively). Lower levels of high sensitivity C-reactive protein, apelin, homeostatic model assessment of insulin resistance (HOMAIR), and appetite score were observed in the zinc group in comparison with the placebo group (P=0.0001, 0.001, 0.031 and 0.001 respectively). Conclusion: This study indicates that Zn supplementation with a restricted calorie diet has favorable efects in reducing anthropometric measurements, infammatory markers, insulin resistance and appetite in individuals with obesity, and may play an efective role in the treatment of obesity. Trial registration This clinical trial was registered at clinicaltrials.gov at the U.S. National Library of Medicine (NCT02516475).

نویسندگان
hide/show

نویسنده نفر چندم مقاله
امید نیک پیامدوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
article 4.pdf1398/09/16702911دانلود